C61 Malignant neoplasm of prostate

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

Additional

code to identify:
hormone sensitivity status (Z19.1-Z19.2)
rising PSA following treatment for malignant neoplasm of prostate (R97.21)

Type 1 Excludes

malignant neoplasm of seminal vesicle (C63.7)

GEM Conversion to ICD-9 CM


MDC / MS-DRG Reference


Back Reference of Diagnostic Codes

Adenocarcinoma See also Neoplasm, malignant, by site
duct
unspecified site
Carcinoma (malignant) See also Neoplasm, by site, malignant
endometrioid
unspecified site
Cystadenocarcinoma See Neoplasm, malignant, by site
endometrioid See Neoplasm, malignant, by site
unspecified site

Sibling Codes


View in Tabular

Code Title
C00-D49 Neoplasms (C00-D49)
C60-C63 Malignant neoplasms of male genital organs (C60-C63)
C61 Malignant neoplasm of prostate
Use Additional
code to identify:
hormone sensitivity status (Z19.1-Z19.2)
rising PSA following treatment for malignant neoplasm of prostate (R97.21)

Type 1 Excludes
malignant neoplasm of seminal vesicle (C63.7)